E-mail from counsel regarding Fed. Cir. decision | Jul 3, 2025 | EXHIBIT | BOARD |
Granting Patent Owner’s Motion to Preserve the Record Pending Appeal 37 C.F.R. 42.5 | Jul 20, 2023 | PAPER | BOARD |
Patent Owner's Notice of Appeal | Jul 14, 2023 | PAPER | PATENT OWNER |
Patent Owner's Motion to Preserve the Record Pending Appeal | Jun 27, 2023 | PAPER | PATENT OWNER |
Final Written Decision: original | May 15, 2023 | PAPER | BOARD |
Order: ORDER Granting Patent Owner’s Second Motion to Seal 37 C.F.R. § 42.54 | May 12, 2023 | PAPER | BOARD |
Other: Hearing transcript | Apr 20, 2023 | PAPER | BOARD |
Other: Hearing transcript | Apr 20, 2023 | PAPER | BOARD |
Patent Owner's Reply Brief Addressing The Board's Questions | Mar 27, 2023 | PAPER | PATENT OWNER |
Petitioner's Reply Supplemental Brief | Mar 27, 2023 | PAPER | PETITIONER |
Patent Owner's Opening Brief Addressing The Board's Questions | Mar 20, 2023 | PAPER | PATENT OWNER |
Petitioner's Opening Supplemental Brief | Mar 20, 2023 | PAPER | PETITIONER |
ORDER Conduct of the Proceeding 37 C.F.R. sec 42.5 | Mar 6, 2023 | PAPER | BOARD |
Redacted Version of Petitioner's Exhibit 1051 Deposition Transcript of John Ferris, dated November 2, 2022 | Mar 1, 2023 | EXHIBIT | PATENT OWNER |
Petitioner's List of Objections to Patent Owner's Demonstratives | Feb 23, 2023 | PAPER | PETITIONER |
Patent Owner's Objections to Petitioner's Demonstratives | Feb 23, 2023 | PAPER | PATENT OWNER |
Patent Owner's Fourth Updated Exhibit List | Feb 22, 2023 | PAPER | PATENT OWNER |
Patent Owner Eye Therapies, LLC's Demonstratives | Feb 22, 2023 | EXHIBIT | PATENT OWNER |
Demonstratives of Petitioner Slayback Pharma LLC | Feb 22, 2023 | PAPER | PETITIONER |
Petitioner's Reply to Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence | Feb 20, 2023 | PAPER | PETITIONER |
Patent Owner's Opposition to Petitioner's Motion to Exclude | Feb 13, 2023 | PAPER | PATENT OWNER |
Patent Owner's Third Updated Exhibit List | Feb 13, 2023 | PAPER | PATENT OWNER |
Declaration of Robert Gorman Jr. in Response to Slayback’s Objections to Patent Owner’s Exhibit Nos. 2028, 2057-2058, 2156, 2166-2168, AND 2195-2196 | Feb 13, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Sur-Reply | Feb 10, 2023 | PAPER | PATENT OWNER |
Patent Owner's Second Motion to Seal | Feb 10, 2023 | PAPER | PATENT OWNER |
Patent Owner's Second Updated Exhibit List | Feb 10, 2023 | PAPER | PATENT OWNER |
Deposition Transcript of Paul A. Laskar, Ph.D., dated January 18, 2023 | Feb 10, 2023 | EXHIBIT | PATENT OWNER |
Deposition Transcript of Dr. Neal A. Sher, M.D., dated January 27, 2023 | Feb 10, 2023 | EXHIBIT | PATENT OWNER |
EXPUNGED | Feb 10, 2023 | EXHIBIT | PATENT OWNER |
ORDER Conduct of the Proceeding 37 C.F.R. sec 42.5 | Feb 7, 2023 | PAPER | BOARD |
Petitioner's Motion to Exclude Evidence | Feb 6, 2023 | PAPER | PETITIONER |
ORDER Granting Patent Owner’s Motion for Entry of Stipulated Protective Order; Granting-in-Part Patent Owner’s Motion to Seal; Denying Petitioner’s Motion to Seal 37 C.F.R. 42.54 | Feb 1, 2023 | PAPER | BOARD |
Joint Stipulation to Modify Schedule for Serving and Filing Demonstratives | Jan 31, 2023 | PAPER | PETITIONER |
ORDER Setting Oral Argument 37 C.F.R. sec 42.70 | Jan 20, 2023 | PAPER | BOARD |
Panel Change Order | Jan 13, 2023 | PAPER | BOARD |
Patent Owner's Request for Oral Hearing | Jan 4, 2023 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Argument | Jan 4, 2023 | PAPER | PETITIONER |
Patent Owner's Notice of Deposition of Ivan T. Hofmann, C.P.A., C.F.F., C.L.P. | Jan 3, 2023 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Paul A. Laskar, Ph.D. | Jan 3, 2023 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Neal A. Sher, M.D., FACS | Jan 3, 2023 | PAPER | PATENT OWNER |
Patent Owner's Objections to Petitioner's Exhibits | Dec 23, 2022 | PAPER | PATENT OWNER |
Side-by-Side Comparison of Figures 2 and 6 of U.S. Patent No. 9,259,425 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Declaration of Neal A. Sher, M.D | Dec 16, 2022 | EXHIBIT | PETITIONER |
Deposition Transcript of Stephen G. Davies, DPhil | Dec 16, 2022 | EXHIBIT | PETITIONER |
Deposition Transcript of John Ferris | Dec 16, 2022 | EXHIBIT | PETITIONER |
Deposition Transcript of John Jarosz | Dec 16, 2022 | EXHIBIT | PETITIONER |
Deposition Transcript of Robert Noecker, M.D. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Health Companies, 2018 Q3 Earnings Call Transcript, dated November 6, 2018 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Deposition Transcript of Robert O. Williams, III, Ph.D | Dec 16, 2022 | EXHIBIT | PETITIONER |
U.S. Pharmacopeia 28-National Formulary 23, 2005 Part 1 of 4 | Dec 16, 2022 | EXHIBIT | PETITIONER |
U.S. Pharmacopeia 28-National Formulary 23, 2005 Part 2 of 4 | Dec 16, 2022 | EXHIBIT | PETITIONER |
U.S. Pharmacopeia 28-National Formulary 23, 2005 Part 3 of 4 | Dec 16, 2022 | EXHIBIT | PETITIONER |
U.S. Pharmacopeia 28-National Formulary 23, 2005 Part 4 of 4 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Conrad, et al. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Gonnering, R. et al | Dec 16, 2022 | EXHIBIT | PETITIONER |
Naphcon A, Alcon Laboratories, Inc. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Srinivasan, S. and Venkiteshwar, M. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Brimonidine Tartrate, Drugs@FDA: FDA-Approved Drugs | Dec 16, 2022 | EXHIBIT | PETITIONER |
Aieta, E.M. & Roberts, P.V. (1985) | Dec 16, 2022 | EXHIBIT | PETITIONER |
NDA: 21-770 Medical Review | Dec 16, 2022 | EXHIBIT | PETITIONER |
Remington: The Science and Practice of Pharmacy | Dec 16, 2022 | EXHIBIT | PETITIONER |
Patent Assignment Search | Dec 16, 2022 | EXHIBIT | PETITIONER |
Ivan T. Hofmann CV and Testimony | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch SEC Form 10-Q, for the period ended June 30, 2022 Part 1 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch SEC Form 10-Q, for the period ended June 30, 2022 Part 2 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Fourth Quarter 2018 Earnings Call Transcript, dated February 20, 2019 Part 1 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Fourth Quarter 2018 Earnings Call Transcript, dated February 20, 2019 Part 2 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Second Quarter 2019 Earnings Call Transcript, dated August 6, 2019 Part 1 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Second Quarter 2019 Earnings Call Transcript, dated August 6, 2019 Part 2 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Fourth Quarter 2020 Earnings Call Transcript, dated February 24, 2021 Part 1 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Fourth Quarter 2020 Earnings Call Transcript, dated February 24, 2021 Part 2 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Fourth Quarter 2021 Earnings Call Transcript, dated February 23, 2022 Part 1 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch Fourth Quarter 2021 Earnings Call Transcript, dated February 23, 2022 Part 2 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
MUSE Creative Awards, dated Apr. 11, 2019 | Dec 16, 2022 | EXHIBIT | PETITIONER |
MUSE Creative Awards | Dec 16, 2022 | EXHIBIT | PETITIONER |
Helen & Gertrude | Dec 16, 2022 | EXHIBIT | PETITIONER |
2019 Silver Winner, Lumify® Redness Reliever Drops | Dec 16, 2022 | EXHIBIT | PETITIONER |
2019 Rose Gold Winner, Lumify® Redness Reliever Drops | Dec 16, 2022 | EXHIBIT | PETITIONER |
Wavemaker US wins two Gold Effie Awards, dated June 3, 2019 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Our Work, Wavemaker | Dec 16, 2022 | EXHIBIT | PETITIONER |
Ben Adams, Bausch + Lomb kicks off TikTok challenge for Lumify | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch + Lomb Launches the #LUMIFYEyeDance Challenge on TikTok | Dec 16, 2022 | EXHIBIT | PETITIONER |
#lumifyeyedance, TikTok | Dec 16, 2022 | EXHIBIT | PETITIONER |
Disclosures 101 for Social Media Influencers, Federal Trade Commission | Dec 16, 2022 | EXHIBIT | PETITIONER |
@Allenface, Tik Tok | Dec 16, 2022 | EXHIBIT | PETITIONER |
@orionsisters, TikTok | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bausch + Lomb #LUMIFYEyeDance Challenge Wins | Dec 16, 2022 | EXHIBIT | PETITIONER |
Wilson, et al. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Solomon, et al. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Langer S.Z. & Hicks, P.E. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Duka, et al. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Philipp M., Brede M., and Hein L. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Angus J.A., Cocks T.M., Wright C.E., Satoh K., and Campbell G.R. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Bockman C.S., Jeffries W.B., Abel P.W. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Spector S.L. & Raizman M.B. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Soparkar, C.N.S., et al. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Stedman’s Medical Dictionary, 28th Ed | Dec 16, 2022 | EXHIBIT | PETITIONER |
Morrow G.L. & Abbott R.L. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Pink Eye (Conjunctivitis), Mayo Clinic | Dec 16, 2022 | EXHIBIT | PETITIONER |
Subconjunctival hemorrhage - American Academy of Ophthalmology | Dec 16, 2022 | EXHIBIT | PETITIONER |
Chapter 43: Ophthalmic Solutions of Remington Part 1 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Chapter 43: Ophthalmic Solutions of Remington Part 2 of 2 | Dec 16, 2022 | EXHIBIT | PETITIONER |
Aslanides I.M., et al. (2005) | Dec 16, 2022 | EXHIBIT | PETITIONER |
Aslanides I.M., et al. (2006) | Dec 16, 2022 | EXHIBIT | PETITIONER |
Hong, S., et al. | Dec 16, 2022 | EXHIBIT | PETITIONER |
Declaration of Ivan T. Hofmann (Redacted) | Dec 16, 2022 | EXHIBIT | PETITIONER |
Declaration of Ivan T. Hofmann (Under Seal) | Dec 16, 2022 | EXHIBIT | PETITIONER |
Declaration of Paul Laskar, Ph.D | Dec 16, 2022 | EXHIBIT | PETITIONER |
Petitioner's Reply (Under Seal) | Dec 16, 2022 | PAPER | PETITIONER |
Petitioner's Reply (Redacted) | Dec 16, 2022 | PAPER | PETITIONER |
Petitioner's Third Updated Exhibit List | Dec 16, 2022 | PAPER | PETITIONER |
Petitioner's Motion to Seal | Dec 16, 2022 | PAPER | PETITIONER |
From Cipriano Linnea P To Trials Cc Diner Bryan Hasford Justin O Connell, Caitlin Yang, Christina Ji-Hye DG-Brimonidine IPRs Frederickson III, Robert Subject: IPR2022-00142 Date November 18, 2022 | Nov 23, 2022 | EXHIBIT | BOARD |
Joint Stipulation to Change Due Dates 2, 3, 5 and 6 | Nov 22, 2022 | PAPER | PETITIONER |
ORDER Conduct of the Proceeding 37 C.F.R. 42.5 | Nov 21, 2022 | PAPER | BOARD |
Petitioner's Notice of Deposition of Dr. Robert Noecker | Oct 28, 2022 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Robert Williams | Oct 28, 2022 | PAPER | PETITIONER |
• Petitioner’s Notice of Deposition of Dr. Stephen G. Davies | Oct 14, 2022 | PAPER | PETITIONER |
Petitioner’s Notice of Deposition of John Ferris | Oct 14, 2022 | PAPER | PETITIONER |
Petitioner’s Notice of Deposition of John C. Jarosz | Oct 14, 2022 | PAPER | PETITIONER |
Joint Stipulation to Change Due Dates 2 and 3 | Sep 9, 2022 | PAPER | PETITIONER |
Petitioner's Objections to Patent Owner's Evidence Submitted with Patent Owner's Response | Sep 6, 2022 | PAPER | PETITIONER |
Patent Owner's Motion to Seal and Enter Stipulated Proposed Protective Order | Aug 29, 2022 | PAPER | PATENT OWNER |
Patent Owner's Response (UNDER SEAL) | Aug 29, 2022 | PAPER | PATENT OWNER |
Patent Owner's Response (PUBLIC VERSION) | Aug 29, 2022 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Aug 29, 2022 | PAPER | PATENT OWNER |
(UNDER SEAL) Declaration of Dr. Robert Noecker | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) Declaration of Dr. Robert Williams | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2020 - (PUBLIC VERSION) Declaration of Dr. Robert Noecker | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) Declaration of John Ferris | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) Declaration of John Jarosz | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2021 - (PUBLIC VERSION) Declaration of Dr. Robert Williams | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) 3.2.P.5.6 Justification of Specifications | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) LUM.0205.USA.21 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2023 - (PUBLIC VERSION) Declaration of John Ferris | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) IRI Panel Data | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2024 - (PUBLIC VERSION) Declaration of John Jarosz | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) IRI Point-of Sale Data | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) Lumify ECP A&U Report 2020 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2028 - (PUBLIC VERSION) 3.2.P.5.6 Justification of Specifications | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) 10-100-0008 Clinical Study Report Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) 11-100-0015 Clinical Study Report Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) 13-100-0005 Clinical Study Report Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2052 - (PUBLIC VERSION) LUM.0205.USA.21 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2057 - (PUBLIC VERSION) IRI Panel Data | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
(UNDER SEAL) NDA 208-44, Sec. 2.3.P.1 Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2058 - (PUBLIC VERSION) IRI Point-of Sale Data | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2156 - (PUBLIC VERSION) Lumify ECP A&U Report 2020 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Stephen Davies | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2166 - (PUBLIC VERSION) 10-100-0008 Clinical Study Report Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
USP 32, General Notices and Requirements | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2167 - (PUBLIC VERSION) 11-100-0015 Clinical Study Report Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
65 Fed. Reg. 83,041 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2168 - (PUBLIC VERSION) 13-100-0005 Clinical Study Report Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Skwietczynski 2012 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Legal Recognition - Standards Categories, USP | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Agarwal 2021 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2196 - (PUBLIC VERSION) NDA 208-44, Sec. 2.3.P.1 Excerpt | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
21 CFR sec. 330.10 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
67 Fed. Reg. 3,060 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Alphagan P (0.1%) - Orange Book | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2108 - lumifydrops.com - FAQ | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Alphagan P (0.15%) - Orange Book | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Drug Application Process for Nonprescription Drugs, FDA | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2109 - lumifydrops.com - home | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Zhu and Chauhan 2008 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Coffey 2013 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Alphagan P 0.15% Chemistry Review | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Alphagan P 0.1% Chemistry Review | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
de Mendoza 2007 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2110 - lumifydrops.com - clinical info | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bagwell 2005 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Congressional Budget Office 2009 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Ching and Ishihara 2012 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2111 - lumifydrops.com - professional | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Gonzalez 2014 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
IRI Report 2020 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2112 - lumifydrops.com - science | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Perloff and Carlton 2015, Part 1 of 2 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2113 - mckinsey.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Perloff and Carlton 2015, Part 2 of 2 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2114 - newyou.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2115 - opthalmologyweb.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Samuelson and Nordhause 2010, Part 1 of 2 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2116 - optometricmanagement.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Samuelson and Nordhause 2010, Part 2 of 2 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2117 - optometrytimes.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Spiegel and Gerber 1959 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2118 - patents.bausch.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Thomas 2011 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Thomas and Melton 2016 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
BAU-LUM00063901 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2119 - pi.bausch.com - drug facts | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
LUM.1827.USA.21 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify_v9 - PRC APRVD | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2120 - pi.bausch.com - max drug facts | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Visine Supplemental Approval, Oct. 17, 2018 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2121 - pink.pharmaintelligence | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify Supplemental Approval, Apr. 30, 2019 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify Supplemental Approval, Feb. 21, 2019 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2122 - pitchbook.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify Supplemental Approval, Mar. 5, 2020 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify Supplemental Approval, Nov. 29, 2021 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify Supplemental Approval, Sept. 23, 2020 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2123 - prestigebrands.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify NDA Approval, Dec. 22, 2017 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2124 - prnewswire.com - Bausch | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify NDA Summary Overview, Nov. 29, 2017 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2125 - prnewswire.com - Nielsen BASES | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch SEC Form 10-Q for the quarterly period ended Mar. 31, 2022 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2126 - prnewswire.com - hydroxyprogesterone | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch Q1 2022 Financial Results | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2127 - prenewswire.com ��� zovirax | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch Jan. 2022 S-1, Part 1 of 3 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch Jan. 2022 S-1, Part 2 of 3 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2128 - prnewswire.com - Slayback Icatibant | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch Jan. 2022 S-1, Part 3 of 3 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2129 - prnewswire.com - Slayback Merzee | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch S-1A Apr. 2022, Part 1 of 3 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch S-1A Apr. 2022, Part 2 of 3 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2130 - reviewofoptometry.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch S-1A Apr. 2022, Part 3 of 3 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Valeant 2017 Annual Report | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Aug 29, 2022 | PAPER | PATENT OWNER |
Bausch 2018 Annual Report | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2132 - riteaid.com - sterile eye drops | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch 2019 Q1 Presentation | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2131 - riteaid.com - redness relief drops | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch 2021 10K, Part 1 of 2 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2133 - rohtoeyedrops.com - All In One | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch 2021 10K, Part 2 of 2 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bausch 2021 FY Presentation | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2134 - rohtoeyedrops.com - Cool Relief | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
J&J 2006 10K | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2135 - rohtoeyedrops.com - Max Strength | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
accessdata.fda.gov - NDA 020065 products | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2136 - rohtoeyedrops.com - Optic Glow | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
accessdata.fda.gov - approved drugs | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
accessdata.fda.gov - lumify orange book | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
accessdata.fda.gov - NDA 020485 products | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2137 - rohtoeyedrops.com - Digi Eye | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
amazon.com - Lumify | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
bausch.com - locations | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
bausch.com - BLCO ticker | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2138 - rohtoeyedrops.com - Redness Reliever | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
bausch.com - redness relief | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
businesswire.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2139 - similasanusa.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cleareyes.com - all redness relief | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cleareyes.com - Complete Sensitive | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cleareyes.com - Cooling | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2140 - slayback-pharma.com - aboutus | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cleareyes.com - Max | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2141 - slayback-pharma.com - products | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cleareyes.com - Directions | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cleareyes.com - Redness Relief | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2142 - slayback-pharma.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cleareyes.com - Traveler's | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cvs.com - eye drops lubricants | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2143 - target.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
cvs.com - Lumify | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
DailyMed Rohto Cool | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
DailyMed Visine | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2144 - thezoereport.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
eyewire.news | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
fda.report Bausch filings | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2145 - us.mentholatum.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
fda.report Prestige filings | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
glamour.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2146 - verywellhealth.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
intothegloss.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
introwellness.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2148 - walgreens.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
ir.bauschhealth.com - Lumify launch | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
ir.bauschhealth.com - Lumify approval | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2149 - walmart.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
ir.bauschhealth.com - name change | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
ir.bauschhealth.com - Valeant | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2150 - walrus.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
ir.nielsen.com | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2151 - accessdata.fda.gov - Lumify label | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2152 - 2018 NACDS Product of the Year | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Scientists discover why cornea is transparent, EurekAlert! | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Sclera_Definition, Anatomy & Function, Cleveland Clinic article | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
American Ophthalmology re Sclera layers | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Sher 1984 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2153 - 2019 April_May BRIDES Best of Beauty Award | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Simbrinza Label | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Soparkar 1997 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Spector 1994 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2154 - 2019 NewBeauty Award Winners - Best Innovations | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Stafford-Smith 2007 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
The Truth about Tachyphylaxis | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Uretmen 2003 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2155 - 2022 New Beauty Beauty Awards - Never Knew We Needed | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Ruffolo 1984 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
US 3,890,319 (Pfizer) | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Lumify label | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2157 - https_www.ipsos.com_en-hk_healthcare | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Naphcon-A label | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Visine L.R. label | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2158 - 2018 Sept Press Release - NACDS Award | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Visine Original label | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Bower 2001 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2159 - 2022 Q2 Presentation | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Deposition Transcript of Dr. Paul Laskar | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Enhancing the Management of Red Eye | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Watts and Hawksworth 2002 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2160 - https_www.iriworldwide.com_en-us_company_about-us | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
IPR2022-00146, Declaration of David Fisher | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2161 - US 8,293,742 (Color) | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2162 - Deposition Transcript of Dr. Neal Sher | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Munoz 2009 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Raviola 1983 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2163 - www.lumifydrops.com_lumify_science | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2165 - Bausch + Lomb Receives FDA Approval of Lumify | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2164 - Lumify Lovers | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2169 - Derick 1995 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2170 - Drug Application Process for Nonprescription Drugs, FDA | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2171 - Definition of ciliary body - NCI Dictionary of Cancer Terms - NCI | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2172 - Eyes_How They Work, Anatomy, & Common Conditions - Cleveland Clinic article | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2173 - Glaucoma symptoms and causes - Mayo Clinic | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
EX-2174 - Morgan 1987 | Aug 29, 2022 | EXHIBIT | PATENT OWNER |
Joint Stipulation to Change Due Date for Patent Owner's Response | Aug 22, 2022 | PAPER | PATENT OWNER |
Granting Petitioners Motions for Admission pro hac vice of Robert Frederickson III 37 C.F.R. § 42.10 | Aug 16, 2022 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices Pursuant to 37 C.F.R. section 42.8 | Aug 5, 2022 | PAPER | PETITIONER |
Petitioner's Unopposed Motion for Pro Hac Vice Admission of Robert Frederickson III under 37 C.F.R. section 42.10(c) | Aug 5, 2022 | PAPER | PETITIONER |
Petitioner's Second Updated Exhibit List | Aug 5, 2022 | PAPER | PETITIONER |
Exhibit 1044 | Aug 5, 2022 | EXHIBIT | PETITIONER |
Petitioner's Updated Power of Attorney | Aug 1, 2022 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Aug 1, 2022 | PAPER | PETITIONER |
Patent Owner's Amended Notice of Deposition of Paul A. Laskar, Ph.D. | Jul 20, 2022 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Neal A. Sher, M.D., FACS | Jul 18, 2022 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Paul A. Laskar, Ph.D. | Jul 14, 2022 | PAPER | PATENT OWNER |
Joint Stipulation to Change Due Date 1 | Jul 12, 2022 | PAPER | PETITIONER |
Order Other Revised Joint Scheduling Order | Jun 28, 2022 | PAPER | BOARD |
Petitioner's Objections to Pre-Institution Exhibits | Jun 2, 2022 | PAPER | PETITIONER |
DECISION Granting Institution of Inter Partes Review 35 U.S.C. 314, 37 C.F.R. 42.4 | May 18, 2022 | PAPER | BOARD |
EXPUNGED | May 18, 2022 | PAPER | BOARD |
JOINT SCHEDULING ORDER | May 18, 2022 | PAPER | BOARD |
Patent Owner's Sur-Reply Regarding Discretionary Denial | Apr 5, 2022 | PAPER | PATENT OWNER |
Petitioner Response to Fintiv and 325(d) Issues in Preliminary Response | Mar 29, 2022 | PAPER | PETITIONER |
Petitioner First Updated Exhibit List | Mar 29, 2022 | PAPER | PETITIONER |
Sotera-type Stipulation to Limit Invalidity Contentions | Mar 29, 2022 | EXHIBIT | PETITIONER |
Order: Conduct of the Proceeding - 37 CFR 42.5 | Mar 23, 2022 | PAPER | BOARD |
Ex. 3001 | Mar 23, 2022 | EXHIBIT | BOARD |
Patent Owner's Preliminary Response | Feb 22, 2022 | PAPER | PATENT OWNER |
Patent Owner's Exhibit List | Feb 22, 2022 | PAPER | PATENT OWNER |
Joint Discovery Plan | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Defs First Requests For Production Nos. 1-2 | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Scheduling Order | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Order setting Initial Scheduling Conference | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Slayback Paragraph-IV Letter | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Complaint Against Slayback (DNJ) | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Cantor 2006 | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
US 6,982,079 ('079 patent) | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Lee 2008 | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
US 5,021,416 ('416 patent) | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Bausch Press Release re Redness | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Alphagan (0.5%; 0.2%) Label (2001) | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Visine-A Label | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Alphagan P (0.15%; 0.1%) Label (2006) | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Alphagan (0.2%) Approval Letter Sept. 1996 | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Drugs@FDA - Alphagan 0.5% | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Drugs@FDA - Alphagan P 0.15% | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Allergan Discontinues Alphagan (Sept. 2002) | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Alphagan P (0.1%) Approval Letter (2005) | Feb 22, 2022 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Jan 13, 2022 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Nov 24, 2021 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney and Designation of Lead and Backup Counsel | Nov 24, 2021 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Nov 22, 2021 | PAPER | BOARD |
Power of Attorney | Nov 4, 2021 | PAPER | PETITIONER |
US 8293742 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Expert Declaration of Neal A. Sher, M.D. | Nov 4, 2021 | EXHIBIT | PETITIONER |
Expert Declaration of Paul A. Laskar, Ph.D. | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Patent 6,294,553 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Walters 1991 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Norden 2002 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Patent 6,242,442 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Alphagan(R) Label 1998 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Federal Register 1988 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Application 12/460,941 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Application 61/207,481 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Application 61/203,120 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Application 61/192,777 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Application 61/137,714 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Timmermans 1980 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Griffith 2003 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Wikberg 2001 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Robin 1998 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Lachkar 1998 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Carlsson 2000 | Nov 4, 2021 | EXHIBIT | PETITIONER |
David 2001 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Schuman 1997 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Scruggs 2000 | Nov 4, 2021 | EXHIBIT | PETITIONER |
File Wrapper U.S. Application 12/460,941 downloaded from PAIR | Nov 4, 2021 | EXHIBIT | PETITIONER |
Pasquali 2013 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Murphy 2007 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Derick 1997 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Burke 1995 | Nov 4, 2021 | EXHIBIT | PETITIONER |
David 1993 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Patent Application Pub. No. 2005/0244463 | Nov 4, 2021 | EXHIBIT | PETITIONER |
CDER Records 20613 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Petition for IPR U.S. Patent 8,293,742 | Nov 4, 2021 | PAPER | PETITIONER |
Rahman 2010 | Nov 4, 2021 | EXHIBIT | PETITIONER |
U.S. Patent 6,562,873 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Chien 1990 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Burke 1996 | Nov 4, 2021 | EXHIBIT | PETITIONER |
Petitioner's Claim Listing | Nov 4, 2021 | EXHIBIT | PETITIONER |